Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees.
By S. Wakitani, K. Imoto, Tetsuya Yamamoto, M. Saito, N. Murata, M. Yoneda. Osteoarthritis and Cartilage, 2002
1,008 citations recorded by the source corpus.
Subfields: Genetics, Rheumatology, Urology
View Paper: https://www.semanticscholar.org/paper/4ac2555163c724ca2003255895ae160e36f591a8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Jianxun Ding
- Yanbo Zhang
- Yu Han
- T. Trzaska
- Y. Ikada
- Xue-zhou Li
- W. Widuchowski
- F. Chang
Citations in the corpus
- Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells (2012, neutral): “tested the role of autologous BM-MSCs in the repair of large articular cartilage defects in the osteoarthritic knees of patients (n = 24) who underwent high tibial osteotomy [187].”
- Challenges in tissue engineering (2006, background): “…2002), maxillary sinus augmentation (Rodriguez et al. 2003), metacarpophalangeal joints (Honkanen et al. 2003), osteoarthritic knee cartilage (Wakitani et al. 2002), osteochondritis dissecans (Ochi et al. 2002; Peterson et al. 2003), myocardial infarction (Wollert et al. 2004), vascular…”
- Mesenchymal Stem Cells for Regenerative Medicine (2019, background): “Despite clinical trials being conducted, there are no commercially available products for MSC-based cartilage reconstruction [82,83].”
- Articular cartilage defects: study of 25,124 knee arthroscopies. (2007, methodology): “Although many new techniques have been introduced [2–8] the treatment of traumatic and non-traumatic cartilage lesions remains a controversial challenge.”